Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other
companies in this sector in Taiwan:
Pharmally International Holding Company Ltd
(2018
sales of 5.18 billion Taiwanese Dollars [US$170.17 million]
of which 35%
was Glass Bottle),
Standard Chem. & Pharm. Co Ltd
(3.57 billion Taiwanese Dollars [US$117.45 million]
of which 58%
was Pharmaceuticals), and
Formosa Laboratories, Inc
(2.69 billion Taiwanese Dollars [US$88.35 million]
of which 100%
was Active Pharmaceutical Ingredient).
Sales Analysis.
Tty Biopharm Company Limited reported sales of 4.04 billion Taiwanese Dollars (US$132.67 million)
for the
year ending
December of 2018.
This
represents
a
decrease of 1.0%
versus 2017, when the company's sales were 4.08 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 11.9% decline
in Anti-Infection Drug, from 803.70 million Taiwanese Dollars to 707.69 million Taiwanese Dollars.
.
However, these declines were partially offset by the increase in sales of
Anti-Cancer Drug (up 2.9% to 2.56 billion Taiwanese Dollars)
and
Cardiovascular and Gastrointestinal Drug (up 6.0% to 515.65 million Taiwanese Dollars)
and
Taipei Branch (up 5.0% to 234.89 million Taiwanese Dollars)
and
Other (up 58.4% to 20.03 million Taiwanese Dollars)
.